title: Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis.
authors.forename: Ladislav
authors.initials: L
authors.lastname: Šenolt
authors.forename: Markéta
authors.initials: M
authors.lastname: Kuklová
authors.forename: Lucie Andrés
authors.initials: LA
authors.lastname: Cerezo
authors.forename: Hana
authors.initials: H
authors.lastname: Hulejová
authors.forename: Maria
authors.initials: M
authors.lastname: Filková
authors.forename: Lenka
authors.initials: L
authors.lastname: Bošanská
authors.forename: Ondřej
authors.initials: O
authors.lastname: Pecha
authors.forename: Karel
authors.initials: K
authors.lastname: Pavelka
authors.forename: Martin
authors.initials: M
authors.lastname: Haluzík
authors.forename: Jiří
authors.initials: J
authors.lastname: Vencovský
mesh_terms: D054392:Adipokines / Q000096:biosynthesis*; D000328:Adult; D018501:Antirheumatic Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor; D050151:Subcutaneous Fat / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D054392:Adipokines; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept